WELL Health Technologies Corp. (TSX:WELL)
Canada · Delayed Price · Currency is CAD 4.180
-0.100 (-2.34%)
Sep 15, 2026, 4:00 PM EST
WELL Health Technologies Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,070 | 1,013 | 1,709 | 929 | 654 | 1,022 | |
Market Cap Growth | -10.34% | -40.69% | 83.84% | 42.20% | -36.05% | -21.82% |
Enterprise Value | 2,065 | 1,709 | 2,110 | 1,371 | 1,056 | 1,428 |
Last Close Price | 4.18 | 3.99 | 6.86 | 3.85 | 2.84 | 4.91 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 282.32 | - | 52.40 | 11335.33 | 477.46 | - |
Forward PE | 15.10 | 41.96 | 226.40 | 196.02 | 196.02 | 196.02 |
PS Ratio | 0.70 | 0.72 | 1.86 | 1.20 | 1.15 | 3.38 |
PB Ratio | 1.07 | 0.98 | 1.84 | 1.10 | 0.80 | 1.44 |
P/FCF Ratio | 12.92 | 12.40 | - | 22.64 | 9.35 | - |
P/OCF Ratio | 8.38 | 8.31 | 179.46 | 13.99 | 8.54 | 45.90 |
PEG Ratio | - | 0.90 | 9.06 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.36 | 1.22 | 2.29 | 1.77 | 1.86 | 4.72 |
EV/EBITDA Ratio | 10.61 | 10.26 | 80.80 | 16.18 | 13.17 | 40.50 |
EV/EBIT Ratio | 22.30 | 18.27 | - | 39.70 | 31.93 | 981.03 |
EV/FCF Ratio | 24.93 | 20.92 | - | 33.39 | 15.10 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.95 | 0.69 | 0.51 | 0.50 | 0.44 | 0.57 |
Debt / EBITDA Ratio | 4.89 | 3.81 | 11.15 | 4.47 | 4.06 | 10.01 |
Debt / FCF Ratio | 11.52 | 8.74 | - | 10.38 | 5.13 | - |
Net Debt / Equity Ratio | 0.82 | 0.56 | 0.37 | 0.45 | 0.38 | 0.48 |
Net Debt / EBITDA Ratio | 4.72 | 3.48 | 13.08 | 4.52 | 3.86 | 9.64 |
Net Debt / FCF Ratio | 9.94 | 7.10 | -20.09 | 9.33 | 4.43 | -11.26 |
Asset Turnover | 0.69 | 0.72 | 0.57 | 0.57 | 0.44 | 0.39 |
Inventory Turnover | 294.44 | 303.08 | 287.61 | 316.70 | 245.81 | 144.23 |
Quick Ratio | 0.72 | 0.94 | 0.87 | 1.33 | 1.06 | 1.00 |
Current Ratio | 0.80 | 1.03 | 0.91 | 1.52 | 1.11 | 1.04 |
Return on Equity (ROE) | 1.64% | 0.45% | 3.28% | 2.00% | 2.45% | -6.76% |
Return on Assets (ROA) | 2.65% | 3.00% | -1.16% | 1.58% | 1.59% | 0.12% |
Return on Invested Capital (ROIC) | 4.55% | 5.44% | -2.39% | 2.50% | 3.05% | 0.24% |
Return on Capital Employed (ROCE) | 4.90% | 5.40% | -2.10% | 2.70% | 2.80% | 0.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.35% | -0.73% | 1.91% | 0.01% | 0.21% | -4.32% |
FCF Yield | 7.74% | 8.06% | -1.00% | 4.42% | 10.70% | -2.96% |
Buyback Yield / Dilution | -1.64% | 0.73% | -7.66% | -7.18% | -15.61% | -42.56% |